2 Biotechs Raise Combined $116M After IPOs Price Low
By Tom Zanki ( October 31, 2019, 3:55 PM EDT) -- Eye-disease treatment company Oyster Point Pharma Inc. and cancer-focused drug developer Rapt Therapeutics Inc. made their public debuts Thursday after raising a combined $116 million in initial public offerings that priced at the bottom of their respective ranges....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.